Media Summary: CEO Aaron J. Kowalski, Ph.D., shares an update on the Aaron J. Kowalski, Ph.D., JDRF Chief Executive Officer, shares the At JDRF, we are committed to funding the development of new therapies to keep people with type 1

T1d Top Advances - Detailed Analysis & Overview

CEO Aaron J. Kowalski, Ph.D., shares an update on the Aaron J. Kowalski, Ph.D., JDRF Chief Executive Officer, shares the At JDRF, we are committed to funding the development of new therapies to keep people with type 1 Drs. Steve Edelman and Jeremy Pettus sit down to share their

Photo Gallery

T1D Top Advances
Breakthrough T1D Top Advances of 2025
Breakthrough T1D Top Advances
Top Advances
JDRF Top Advances
Top T1D Advances of the Year
FY21 Top Research Advances
T1Dto100: GLP1s & T1D: What You Actually Need to Know, 6/17/2026
JDRF Top Advances 2020
2026 Diabetes Predictions: Retatrutide, Oral GLP-1s, Stem Cell Breakthroughs… and more!
In the News... Tzield approved for newly diagnosed T1D, GLP-1 studies for type 1, ADA 2026...
JDRF Top Advances 2019
View Detailed Profile
T1D Top Advances

T1D Top Advances

CEO Aaron J. Kowalski, Ph.D., shares an update on the

Breakthrough T1D Top Advances of 2025

Breakthrough T1D Top Advances of 2025

Breakthrough

Breakthrough T1D Top Advances

Breakthrough T1D Top Advances

Breakthrough

Top Advances

Top Advances

Aaron J. Kowalski, Ph.D., JDRF Chief Executive Officer, shares the

JDRF Top Advances

JDRF Top Advances

JDRF made exciting

Top T1D Advances of the Year

Top T1D Advances of the Year

Breakthrough

FY21 Top Research Advances

FY21 Top Research Advances

... disease and get it back to a pre-

T1Dto100: GLP1s & T1D: What You Actually Need to Know, 6/17/2026

T1Dto100: GLP1s & T1D: What You Actually Need to Know, 6/17/2026

There's a BIG shift in the

JDRF Top Advances 2020

JDRF Top Advances 2020

At JDRF, we are committed to funding the development of new therapies to keep people with type 1

2026 Diabetes Predictions: Retatrutide, Oral GLP-1s, Stem Cell Breakthroughs… and more!

2026 Diabetes Predictions: Retatrutide, Oral GLP-1s, Stem Cell Breakthroughs… and more!

Drs. Steve Edelman and Jeremy Pettus sit down to share their

In the News... Tzield approved for newly diagnosed T1D, GLP-1 studies for type 1, ADA 2026...

In the News... Tzield approved for newly diagnosed T1D, GLP-1 studies for type 1, ADA 2026...

It's In The News - a look at the

JDRF Top Advances 2019

JDRF Top Advances 2019

POWERFUL PROOF-OF-CONCEPT ...

Could This Technology Cure Type 1 Diabetes?

Could This Technology Cure Type 1 Diabetes?

JOIN THE